利用RNAi技术下调VEGF表达对血管瘤内皮细胞的影响(3)
 |
| 第1页 |
参见附件(2476KB，4页)。
[参考文献]
[1]Elsayes KM, Menias CO, Dillman JR, et al. Vascular malformation and hemangiomatosis syndromes: spectrum of imaging manifestations[J]. 2008.
[2]Coultas L,Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development[J]. Nature,2005,438(7070):937-945.
[3]王莉,张端莲,陕声国,等.血管瘤内皮细胞培养方法的改进及鉴定[J].数理医药学杂志,2005,18(6):522-523.
[4]洪莉,肖现民,盛民立,等. 增生期血管瘤血管内皮细胞培养[J].上海医科大学学报,1999, 26(1): 65-66.
[5]Mulliken J B, Fishman S J, Burrows P E. Vascular anomalies[J]. Curr Probl Surg, 2000,37(8):517-584.
[6]Boye E,Jinnin M,Olsen B R. Infantile hemangioma: challenges, new insights, and therapeutic promise[J]. J Craniofac Surg,2009,20,Suppl 1: 678-684.
[7]Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J]. Nature,1996,380(6573): 435-439.
[8]Chang J,Most D,Bresnick S,et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis[J]. Plast Reconstr Surg,1999, 103(1): 1-9,10.
[9]Jinnin M,Medici D,Park L,et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma[J]. Nat Med,2008,14(11): 1236-1246.
[10]Berard M, Sordello S, Ortega N, et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas[J]. Am J Pathol,1997,150(4):1315-1326 ......
您现在查看是摘要介绍页，详见PDF附件(2476KB，4页)。